(Q47921159)

6 February 2018

title

Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array (English)

1 reference

6 February 2018

author name string

Elizabeth R Proos

series ordinal

1

1 reference

6 February 2018

James H Prescott

series ordinal

2

1 reference

6 February 2018

Mark A Staples

series ordinal

3

1 reference

6 February 2018

publication date

1 June 2008

1 reference

6 February 2018

published in

Pharmaceutical Research

1 reference

6 February 2018

volume

25

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

1387-1395

1 reference

6 February 2018

Solid-Phase Synthesis of the Biologically Active N-Terminal 1—34 Peptide of Human Parathyroid Hormone

cites work

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS11095-008-9544-0

21 January 2018

12 December 2020

Analysis of non-covalent aggregation of synthetic hPTH (1-34) by size-exclusion chromatography and the importance of suppression of non-specific interactions for a precise quantitation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-008-9544-0

Isolation of human parathyroid hormone.

21 January 2018

1 reference

12 December 2020

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)

1 reference

12 December 2020

Dosage form development, in vitro release kinetics, and in vitro-in vivo correlation for leuprolide released from an implantable multi-reservoir array.

1 reference

12 December 2020

Controlling deamidation rates in a model peptide: effects of temperature, peptide concentration, and additives

1 reference

12 December 2020

The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody

1 reference

12 December 2020

The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats

1 reference

12 December 2020

Electrothermally activated microchips for implantable drug delivery and biosensing

1 reference

12 December 2020

Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone

1 reference

12 December 2020

Non-compliance: the Achilles' heel of anti-fracture efficacy

1 reference

12 December 2020

Osteoporosis, the deafening silent epidemic

1 reference

12 December 2020

Challenges in the development of high protein concentration formulations

1 reference

12 December 2020

Purification of human parathyroid hormone: recent studies and further observations

1 reference

12 December 2020

Patient willingness to take teriparatide

1 reference

12 December 2020

Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34)

1 reference

12 December 2020

Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats

1 reference

12 December 2020

Who are candidates for prevention and treatment for osteoporosis?

1 reference

12 December 2020

Crystalline monoclonal antibodies for subcutaneous delivery

1 reference

12 December 2020

Lyophilization and development of solid protein pharmaceuticals

1 reference

12 December 2020

Oral delivery of biologically active parathyroid hormone

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

1 reference

12 December 2020

Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device.

1 reference

12 December 2020

Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone

1 reference

12 December 2020

Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats.

1 reference

12 December 2020

10.1007/S11095-008-9544-0

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018